RÉSUMÉ
Breast cancer continues to be one of the main causes of morbidity and mortality globally and was the leading cause of cancer death in women in Spain in 2020. Early diagnosis is one of the most effective methods to lower the incidence and mortality rates of breast cancer. The human metalloproteinases (MMP) mainly function as proteolytic enzymes degrading the extracellular matrix and plays important roles in most steps of breast tumorigenesis. This retrospective cohort study shows the immunohistochemical expression levels of MMP-1, MMP-2, MMP-3, and MMP-9 in 154 women with breast cancer and 42 women without tumor disease. The samples of breast tissue are assessed using several tissue matrices (TMA). The percentages of staining (≤50%->50%) and intensity levels of staining (weak, moderate, or intense) are considered. The immunohistochemical expression of the MMP-1-intensity (p = 0.043) and MMP-3 percentage (p = 0.018) and intensity, (p = 0.025) present statistically significant associations with the variable group (control-case); therefore, expression in the tumor tissue samples of these MMPs may be related to the development of breast cancer. The relationships between these MMPs and some clinicopathological factors in breast cancer are also evaluated but no correlation is found. These results suggest the use of MMP-1 and MMP-3 as potential biomarkers of breast cancer diagnosis.
Sujet(s)
Tumeurs du sein/métabolisme , Matrix metalloproteinase 1/métabolisme , Matrix metalloproteinase 3/métabolisme , Sujet âgé , Sujet âgé de 80 ans ou plus , Marqueurs biologiques tumoraux/génétique , Région mammaire/anatomopathologie , Tumeurs du sein/diagnostic , Tumeurs du sein/génétique , Études cas-témoins , Études de cohortes , Évolution de la maladie , Femelle , Humains , Immunohistochimie/méthodes , Matrix metalloproteinase 1/génétique , Matrix metalloproteinase 2/métabolisme , Matrix metalloproteinase 3/génétique , Matrix metalloproteinase 9/métabolisme , Metalloproteases/génétique , Metalloproteases/métabolisme , Adulte d'âge moyen , Études rétrospectives , Espagne , Inhibiteur tissulaire des métalloprotéinases/métabolismeRÉSUMÉ
Improving knowledge on the epidemiology and analysing the prognostic factors of severity for injuries caused by fighting bulls in Spain, Portugal and southern France. Observational retrospective study including 1239 patients with a reported history of bull horn injuries between January 2012 and November 2019 in Spain, Portugal or southern France. A multiple logistic regression test was used to analyse the prognostic factors of severity and mortality rate of these lesions. The mean accident rate was 9.13% and the mortality rate was 0.48%. The most frequent mechanism of trauma was goring, and the commonest locations of the lesions were thigh and groin. Vascular lesion was found in 20% of thigh/groin gorings. Prognostic factors of severity were vascular lesion, head trauma, fracture, goring injuries and age of the animal. The most reliable prognostic factors of mortality were vascular lesion and goring in the back. Lesions caused by fighting bulls are common in the bullfighting events held in Spain, Portugal and southern France. Although the mortality rate is low, there is a higher morbidity rate, which is conditioned by vascular lesion. All medical teams should include a surgeon experienced in vascular surgery and an anaesthesiologist.
Sujet(s)
Accidents/statistiques et données numériques , Traumatismes sportifs/épidémiologie , Traumatismes cranioencéphaliques/épidémiologie , Fractures osseuses/épidémiologie , Plaies pénétrantes/épidémiologie , Adolescent , Adulte , Animaux , Bovins , Femelle , France/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Portugal/épidémiologie , Études rétrospectives , Espagne/épidémiologie , Facteurs temps , Jeune adulteRÉSUMÉ
OBJETIVO: Revisión bibliográfica del diagnóstico, tratamiento y supervivencia del carcinoma de mama metastásico que cursa con carcinomatosis peritoneal. PACIENTES Y MÉTODOS: Presentamos el caso de una paciente en tratamiento en nuestro hospital comentándose los aspectos clínicos, diagnósticos y terapéuticos de interés. CONCLUSIÓN: Las metástasis del tracto gastrointestinal extra-hepáticas secundarias a tumor de mama son poco comunes (8-10%). La carcinomatosis peritoneal presenta una baja incidencia, habiéndose descrito pocos casos en la literatura, siendo la mayoría de tipo lobulillar infiltrante. Nuestro caso tratado de carcinomatosis peritoneal de origen mamario ductal infiltrante lo hace aún más infrecuente
AIM: We provide a literature review of the diagnosis, treatment and survival of metastatic breast cancer with peritoneal carcinomatosis. PATIENTS AND METHODS: We present a case treated in our institution and discuss relevant clinical, diagnostic, and therapeutic features. CONCLUSION: Extra-hepatic gastrointestinal metastasis from breast cancer is infrequent (8%-10%). The incidence of peritoneal carcinomatosis is low, with few cases reported in the literature, mostly from invasive lobular carcinoma. Our case of invasive ductal carcinoma is even less frequent
Sujet(s)
Humains , Femelle , Adulte d'âge moyen , Tumeurs du sein/anatomopathologie , Carcinome canalaire du sein/anatomopathologie , Tumeurs du péritoine/secondaire , Tumeurs du sigmoïde/anatomopathologie , Tumeurs primitives multiples/anatomopathologie , Adénocarcinome/anatomopathologie , Tumeurs du péritoine/anatomopathologie , Tumeurs du sigmoïde/secondaireRÉSUMÉ
AIM: The surgical margin is usually considered an important prognostic factor in oral oncology. However, the real value of a close surgical margin and its relationship with survival is still unclear. Thus, the present report sought to identify the relationship between close surgical margins and overall 3-year survival, whilst also analyzing the association between such margins and recurrence. MATERIALS AND METHODS: The medical records of 200 patients affected by oral squamous cell carcinoma were retrospectively reviewed. The patients were divided into three groups: positive margin (0-2 mm), close margin (2-5 mm), and negative margin (>5 mm). The relationship between surgical margins and overall survival and recurrence rate was analyzed. RESULTS: Surgical margins and reoperation were found to have no significant association with overall survival (P > 0.05). Overall survival was 63% in our sample. Specifically, this was 50%, 64.7% and 66.2% in patients with positive, close and free margins, respectively. Perineural invasion, pN, and locoregional or cervical recurrences were the factors most directly related to overall survival. DISCUSSION: The results of this study indicate that surgical margins are not directly related to overall survival and other factors might significantly influence patient outcomes. Advanced T stage, node involvement, perineural invasion, and ECS are strongly linked with patient survival (P < 0.05). These findings should be carefully evaluated in patients with close surgical margins. Our results indicate that an aggressive adjuvant treatment of patients with close surgical margins could help in obtaining a similar pattern of overall survival with patients with negative margins.
Sujet(s)
Carcinome épidermoïde/anatomopathologie , Marges d'exérèse , Tumeurs de la bouche/anatomopathologie , Récidive tumorale locale/anatomopathologie , Procédures de chirurgie opératoire/mortalité , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Carcinome épidermoïde/chirurgie , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Tumeurs de la bouche/chirurgie , Invasion tumorale , Récidive tumorale locale/chirurgie , Pronostic , Études rétrospectives , Taux de survie , Jeune adulteRÉSUMÉ
AIM: The main of the present report is to evaluate the utility of intraoperative cytological analysis of medullary bone to predict the extension of bone infiltration in segmental mandibulectomy. MATERIALS AND METHOD: Between the years 2016 and 2018, a total of 17 previously untreated patients with squamous cell carcinoma of the oral cavity underwent a segmental mandibular resection and intraoperative cytological analysis of the bone medullary at Virgen de las Nieves University Hospital (HUVN). The results of the intraoperative cytological analysis were compared with the result of the postoperative histopathological examination and sensitivity, specificity, positive predictive value, and negative predictive value of the test were calculated. RESULTS: Cytological analysis was positive in three patients and the bone resection was consequently extended. All the extensions of these bone margins were clean following the postoperative histological examination. However, two other patients previously classified as clean with intraoperative cytological analysis of bone medullary presented infiltration of bone margins postoperatively. The protocol demonstrated a high negative predictive value (85,7%). The positive predictive value, sensitivity, and specificity were 33,3%, 33,3%, and 85,7% respectively. CONCLUSION: Intraoperative cytological analysis of bone medullary could represent an easy, fast, reliable and inexpensive method to reduce the rate of r1 surgeries attributable to the infiltration of the bone margin. This may have a positive impact on overall survival without increasing the duration and the iatrogenicity of surgery.
Sujet(s)
Carcinome épidermoïde/chirurgie , Ostéotomie mandibulaire/méthodes , Marges d'exérèse , Surveillance peropératoire/méthodes , Tumeurs de la bouche/chirurgie , Adulte , Sujet âgé , Ponction-biopsie à l'aiguille , Moelle osseuse/anatomopathologie , Carcinome épidermoïde/diagnostic , Carcinome épidermoïde/mortalité , Études de cohortes , Cytodiagnostic/méthodes , Femelle , Études de suivi , Hôpitaux universitaires , Humains , Immunohistochimie , Mâle , Adulte d'âge moyen , Tumeurs de la bouche/diagnostic , Tumeurs de la bouche/mortalité , Invasion tumorale/anatomopathologie , Stadification tumorale , Pronostic , Études rétrospectives , Sensibilité et spécificité , Espagne , Résultat thérapeutiqueRÉSUMÉ
INTRODUCTION: Mortality following surgery for lung cancer increases at 90 days. The objective of this study was to determine the rate, factors, time to death, hospital stay until discharge, time to death after discharge and causes of mortality at 90 days following surgery for lung cancer. METHODS: A prospective follow-up study was performed in a cohort of 378 patients who underwent surgery for lung cancer between January 2012 and December 2016. Data on preoperative status, postoperative complications, and mortality were collected. RESULTS: Rates of mortality were 1.6% vs. 3.2% at 30 and 90 days, respectively. Half of deaths occurred between 31 and 90 postoperative days following discharge. The variables found to be related to mortality at 90 days were a Charlson Index >3 (pâ¯<â¯0.001), a history of stroke (pâ¯=â¯0.036), postoperative pneumonia (pâ¯=â¯0.001), postoperative pulmonary or lobar collapse (pâ¯=â¯0.001), reintubation (pâ¯<â¯0.001) and postoperative arrhythmia (pâ¯=â¯0.0029). The risk of mortality was also observed to be associated with the type of surgical technique -being higher for thoracotomy as compared to video-assisted thoracoscopy (VATS) (pâ¯=â¯0.011) -, and hospital readmission after discharge (pâ¯<â¯0.001). Adjusted odds ratios (OR) and 95% confidence intervals (95% CI) were calculated. Multivariate analysis revealed that a Charlson Index >3 (pâ¯=â¯0.001) OR 2.0 (1.55,2.78), a history of stroke (pâ¯=â¯0.018) OR 5.1 (1.81, 32.96) and postoperative pulmonary or lobar collapse (pâ¯=â¯0.001) OR 8.5 (2.41,30.22) were independent prognostic factors of mortality. The most common causes of death were related to respiratory (58.3%) and cardiovascular (33.2%) complications. CONCLUSIONS: Mortality at 90 days following surgery for lung cancer doubles 30-day mortality, which is a relevant finding of which both, patients and healthcare should be aware. Half the deaths within 90 days after surgery for lung cancer occur after discharge. Specific outpatient follow-up programs should be designed for patients at a higher risk of 90-day mortality.
Sujet(s)
Carcinome pulmonaire non à petites cellules/mortalité , Tumeurs du poumon/mortalité , Sortie du patient/statistiques et données numériques , Pneumonectomie/mortalité , Complications postopératoires/mortalité , Thoracotomie/mortalité , Sujet âgé , Carcinome pulmonaire non à petites cellules/anatomopathologie , Carcinome pulmonaire non à petites cellules/chirurgie , Études de cohortes , Femelle , Études de suivi , Humains , Durée du séjour , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/chirurgie , Mâle , Pronostic , Taux de survieRÉSUMÉ
BACKGROUND: The purpose of this study was to assess the rate, cause, and factors associated with readmissions following pulmonary resection for lung cancer and their relationship with 90-day mortality. METHODS: A prospective cohort study was conducted of 379 patients who underwent surgery for lung cancer at the university hospitals Granada, Spain between 2012 and 2016. RESULTS: The rate of readmissions within 30 postoperative days was 6.2%. The most common reason for readmission was subcutaneous emphysema (21.7%), pneumonia (13%), and pleural empyema (8.5%). A higher probability of requiring urgent readmission was associated with a higher Charlson index (OR 2.0,95% confidence interval 1.50-2.67, P = 0.001); peripheral arterial vasculopathy (OR 4.8, 95%CI 1.27-18.85, P = 0.021); a history of stroke (OR 8.2, 95%CI 1.08-62.37, P = 0.04); postoperative atelectasis (OR 4.7, 95%CI 1.21-18.64, P = 0.026); and air leaks (OR 12.6, 95%CI 4.10-38.91, P = 0.001).The prediction multivariable model for readmission represents an area under the curve (ROC) of 0.90. Mortality at 90 postoperative days in the group of readmitted patients was 13% versus 1.5 for the group of patients who did not require readmission (P < 0.001). CONCLUSIONS: The factors predictive for readmission can help design individualized outpatient follow-up plans and programs for the reduction of readmissions.
Sujet(s)
Tumeurs du poumon/mortalité , Réadmission du patient/statistiques et données numériques , Complications postopératoires/mortalité , Sujet âgé , Femelle , Études de suivi , Humains , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/chirurgie , Mâle , Sortie du patient , Pronostic , Études prospectives , Facteurs de risque , Taux de survie , Facteurs tempsRÉSUMÉ
Consequences of the obesity epidemic on cancer morbidity and mortality are not fully appreciated. Obesity is a risk factor for many cancers, but the mechanisms by which it contributes to cancer development and patient outcome have yet to be fully elucidated. Here, we examined the effects of coculturing human-derived adipocytes with established and primary breast cancer cells on tumorigenic potential. We found that the interaction between adipocytes and cancer cells increased the secretion of proinflammatory cytokines. Prolonged culture of cancer cells with adipocytes or cytokines increased the proportion of mammosphere-forming cells and of cells expressing stem-like markers in vitro. Furthermore, contact with immature adipocytes increased the abundance of cancer cells with tumor-forming and metastatic potential in vivo. Mechanistic investigations demonstrated that cancer cells cultured with immature adipocytes or cytokines activated Src, thus promoting Sox2, c-Myc, and Nanog upregulation. Moreover, Sox2-dependent induction of miR-302b further stimulated cMYC and SOX2 expression and potentiated the cytokine-induced cancer stem cell-like properties. Finally, we found that Src inhibitors decreased cytokine production after coculture, indicating that Src is not only activated by adipocyte or cytokine exposures, but is also required to sustain cytokine induction. These data support a model in which cancer cell invasion into local fat would establish feed-forward loops to activate Src, maintain proinflammatory cytokine production, and increase tumor-initiating cell abundance and metastatic progression. Collectively, our findings reveal new insights underlying increased breast cancer mortality in obese individuals and provide a novel preclinical rationale to test the efficacy of Src inhibitors for breast cancer treatment.
Sujet(s)
Adipocytes/métabolisme , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Cytokines/métabolisme , Obésité/complications , ARN messager/métabolisme , src-Family kinases/métabolisme , Adipocytes/cytologie , Animaux , Tumeurs du sein/anatomopathologie , Évolution de la maladie , Femelle , Humains , Souris , ARN messager/génétique , Facteurs de transcription SOX-B1 , Transduction du signal , Transfection , src-Family kinases/génétiqueRÉSUMÉ
Introducción En la actualidad el tratamiento de la vía biliar extrahepática afectada por cáncer, estenosis, lesiones iatrogénicas y otras patologías consiste en la resección de las mismas, y una anastomosis en los casos más graves de la placa hiliar biliar al intestino delgado. Material y métodos Nuestro grupo ha desarrollado un tubo tridimensional de colágeno y agarosa para reparar la vía biliar. Se emplearon 40 animales de experimentación, que fueron estudiados fisiológica e histológicamente a las 4 semanas, 3 y 6 meses. Conclusiones Nuestras prótesis mostraron gran histocompatibilidad y mantenían una normofisiología que hace pensar en las posibles aplicaciones clínicas que podrían tener en un futuro (AU)
Introduction In recent years, with widespread laparoscopic cholecystectomy and liver transplantation, complications involving the biliary system are increasing. All current techniques have a high risk of recurrence or high-morbidity. Material and methods A 3-dimensional collagen bile duct modified with agarose hydrogel was developed to substitute the affected extrahepatic bile duct. It was used in 40 guinea pigs and the histology and physiology was studied at 4 weeks, 3 and 6 months after transplantation. Conclusions The graft shows to have a high potential in applications to treat hepatobiliary diseases which require surgery (AU)
Sujet(s)
Animaux , Conduits biliaires extrahépatiques/chirurgie , Tumeurs des canaux biliaires/chirurgie , Cholestase extrahépatique/chirurgie , Anastomose chirurgicale/instrumentation , Cathéters , Ingénierie tissulaire/méthodes , Modèles animaux de maladie humaine , /méthodesRÉSUMÉ
INTRODUCTION: In recent years, with widespread laparoscopic cholecystectomy and liver transplantation, complications involving the biliary system are increasing. All current techniques have a high risk of recurrence or high-morbidity. MATERIAL AND METHODS: A 3-dimensional collagen bile duct modified with agarose hydrogel was developed to substitute the affected extrahepatic bile duct. It was used in 40 guinea pigs and the histology and physiology was studied at 4 weeks, 3 and 6 months after transplantation. CONCLUSIONS: The graft shows to have a high potential in applications to treat hepatobiliary diseases which require surgery.
Sujet(s)
Conduits biliaires extrahépatiques/chirurgie , Collagène , Prothèses et implants , Animaux , Procédures de chirurgie des voies biliaires/méthodes , Matériaux biocompatibles , Cochons d'Inde , Conception de prothèseRÉSUMÉ
PURPOSE: To evaluate the efficacy of FDG-PET in the definition of tumour lung node lesions and to compare the diagnostic validity of CT and FDGPET in the staging of patients with non-small cell lung cancer (NSCLC). MATERIAL AND METHODS: Patients with clinical suspicion of potentially resectable NSCLC (n = 108) were studied by standard procedures in our setting, including fibrobronchoscopy, transthoracic fine-needle aspiration, thoracoabdominal CT and FDG-PET. PET images were analysed by researchers blinded to results of other imaging modalities. Definitive tumour diagnosis was by histopathological study in patients who underwent surgery and by specific imaging methods and biopsy, when available, in patients who did not. Diagnostic accuracy was evaluated by comparing CT/PET results with the definitive diagnosis. RESULTS: In 13% of patients, no FDG-PET findings were observed and the histological study was negative for tumour. In 22% of patients, FDG-PET detected metastatic disease (M0 by CT). For mediastinal involvement, global diagnostic accuracy was 0.90 with FDG-PET and 0.59 with CT. False positive FDG-PET findings were produced by inflammatory conditions and false negative findings by the small size or proximity of lymph nodes to primary tumour. Mediastinal staging by CT and FDG-PET was correct in 56% and 87% of patients, respectively. CT indicated mediastinal invasion in 17% of patients with no FDG-PET finding of mediastinal involvement. Conversely, mediastinal spread was undetected by CT in 14% of patients with FDG-PET findings of mediastinal involvement. CONCLUSIONS: Although complementary, the functional method (FDG-PET) is significantly superior to the structural method (CT) for detection of mediastinal tumour disease.